Bicycle Therapeutics PLC (NASDAQ:BCYC)
| 20.09 Delayed Data As of Sep 22 |  -1.46 / -6.77%Today’s Change | 18.84 Today|||52-Week Range 33.49 | -32.13% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Operating Activities | Net Income / Starting Line | -13.5M | -17.0M | -21.8M | -- | |
| Depreciation | 269.3K | 335.6K | 710.8K | -- | ||
| Total Other Cash Flow | 122.7K | 2.0M | 1.7M | -- | ||
| Funds From Operations | -13.1M | -14.7M | -19.4M | -- | ||
| Funds From/For Other Operating Expenses | -1.9M | -13.2M | 6.6M | -- | ||
| Net Cash Flow - Operating Activities | -11.3M | -1.4M | -26.0M | -- | ||
| Investing | Capital Expenditures | -243.4K | -1.1M | -1.2M | -- | |
| Net Cash Flow Investing | -243.4K | -1.1M | -1.2M | -- | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | -- | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | -- | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | -- | -- | |
| Net Proceeds Stock Sale | 16.8M | 58.5M | 25.4M | -- | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | -- | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | -- | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | -- | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | -- | -- | |
| Net Cash Flow - Financing | 16.8M | 58.5M | 25.4M | -- | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -1.8M | 2.9M | -2.4M | -- | |
| Net Change In Cash | 5.3M | 55.9M | -1.8M | -- | ||
